Hurone AI Leads National Cancer Care Transformation: Contributing to the 2024 President's Cancer Panel Report

Hurone AI at the Forefront of National Healthcare Policy

Hurone AI is proud to announce our significant contribution to the 2024 President’s Cancer Panel’s landmark report, “Enhancing Patient Navigation with Technology to Improve Equity in Cancer Care,” submitted directly to the President of the United States. This prestigious recognition positions Hurone AI as a national thought leader in AI-powered cancer care transformation and validates our strategic approach to addressing systemic healthcare inequities.

Aligning Innovation with National Priorities

The President’s Cancer Panel report calls for bold integration of technology into patient navigation, improved data interoperability, and expanded use of responsible AI—recommendations that directly mirror Hurone AI’s core mission and proven capabilities. Our founder and CEO, Dr. Kingsley Ndoh, contributed expert insights that helped shape these national healthcare priorities, demonstrating Hurone AI’s unique position as both an industry innovator and policy influencer.

Proven Platform Delivering Measurable Impact

At Hurone AI, we’re not just talking about the future of cancer care. We’re delivering it today. Hurone’s humanoid patient platform, Hurona, represents the next generation of responsible, explainable, and adaptive AI that empowers patients and oncologists with actionable insights while reducing patient costs and improving care delivery. These capabilities directly address the report’s vision to reduce disparities and improve efficiency in healthcare systems nationwide.

Key Platform Achievements:

  • Measurable patient outcomes through AI-powered navigation
  • Reduced healthcare costs via optimized care delivery
  • Enhanced clinical decision support for oncologists
  • Improved care equity across diverse patient populations

Our founder, Dr. Kingsley Ndoh, with members of the President Cancer Panel: L to R: Dr. Mitch Berger, Director UCSF Brain Tumor center, Dr. Elizabeth Jaffee, Deputy Director, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center; Dr. Carol Brown, Snr Vice President, Memorial Sloan Kettering Cancer Center

Market Validation Through Policy Leadership

The President’s Cancer Panel report serves as unprecedented market validation for Hurone AI’s strategic direction. When national healthcare policy aligns with a company’s core mission and capabilities, it signals:

  • Massive market opportunity supported by federal priorities
  • Regulatory tailwinds favoring AI-powered healthcare solutions
  • Competitive advantage through early policy alignment
  • Sustainable growth potential backed by national healthcare transformation

The Future of Cancer Care is Here

The President’s Cancer Panel report represents more than policy recommendations—it’s a roadmap for the future of cancer care, and Hurone AI is uniquely positioned to lead this transformation. Our technology doesn’t just meet today’s healthcare challenges; it anticipates and solves tomorrow’s needs.

As the healthcare industry moves toward AI-powered patient navigation and precision medicine, Hurone AI stands ready to capture the enormous opportunity ahead. Our contribution to national healthcare policy, combined with our proven platform and strategic partnerships, positions us as the definitive leader in AI-powered cancer care transformation.

 

About Hurone AI: Hurone AI is the leading developer of responsible AI solutions for cancer care, empowering patients and clinicians through innovative technology that improves outcomes, reduces costs, and advances health equity. With strategic partnerships spanning academic medical centers, cloud infrastructure providers, and international health organizations, Hurone AI is transforming cancer care on a global scale.

Floria Nyandaya

Research Fellow | Program Manager, Hurone AI

Floria Nyandaya is a physician-scientist dedicated to tackling health disparities in non-communicable diseases(NCDs) amidst Africa’s epidemiological transition. 

With a diverse background in primary clinical practice, healthcare management, infectious disease surveillance and NCD research, she has recently expanded her focus to digital health technologies. As a recipient of the Cardiometabolic Research Fellowship and the Thomas Francis Jr. Global Health Fellowship in her MPH program, Floria gained hands-on global health experience in the U.S., Nigeria, and Kenya. 

Her research endeavors have been multifaceted, from advancing women’s cardiovascular health to exploring the utility of artificial intelligence in enhancing renal and cancer care and addressing diversity gaps in clinical trial research. Continuously driven by her passion for making a tangible difference, Floria remains dedicated to improving the health and well-being of underserved populations.

 
Marko Stanojević

Engineering Product Manager, Hurone AI

Marko is the Engineering Product Manager at Hurone AI. He has a Bachelor of Science in Computer Science from the Belgrade Institute of Technology. His expertise in software engineering and product development plays a key role in Hurone AI’s success.

Marko’s ability to bridge technology and user experience has been vital in driving the launch of Hurone AI’s innovative products. His collaborative approach and adaptability ensure that the company’s solutions meet the highest standards.

Outside of work, Marko is passionate about technology and stays updated on the latest industry trends. His commitment to continuous learning makes him an invaluable asset to the Hurone AI team.